Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
CC BY
Lưu vào:
| Tác giả chính: | , , |
|---|---|
| Định dạng: | Sách |
| Ngôn ngữ: | English |
| Nhà xuất bản: |
Springer
2023
|
| Chủ đề: | |
| Truy cập trực tuyến: | https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 |
| Từ khóa: |
Thêm từ khóa
Không có từ khóa, Hãy là người đầu tiên đánh dấu biểu ghi này!
|
| id |
oai:localhost:PNK-7298 |
|---|---|
| record_format |
dspace |
| spelling |
oai:localhost:PNK-72982023-03-29T08:40:50Z Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial Marius, Trøseid José R., Arribas Lambert, Assoumou Bari-SolidAct placebo-controlled phase 3 trial CC BY Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants. 2023-03-29T08:40:50Z 2023-03-29T08:40:50Z 2023 Book https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 en application/pdf Springer |
| institution |
Digital Phenikaa |
| collection |
Digital Phenikaa |
| language |
English |
| topic |
Bari-SolidAct placebo-controlled phase 3 trial |
| spellingShingle |
Bari-SolidAct placebo-controlled phase 3 trial Marius, Trøseid José R., Arribas Lambert, Assoumou Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| description |
CC BY |
| format |
Book |
| author |
Marius, Trøseid José R., Arribas Lambert, Assoumou |
| author_facet |
Marius, Trøseid José R., Arribas Lambert, Assoumou |
| author_sort |
Marius, Trøseid |
| title |
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| title_short |
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| title_full |
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| title_fullStr |
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| title_full_unstemmed |
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial |
| title_sort |
efficacy and safety of baricitinib in hospitalized adults with severe or critical covid-19 (bari-solidact): a randomised, double-blind, placebo-controlled phase 3 trial |
| publisher |
Springer |
| publishDate |
2023 |
| url |
https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 |
| _version_ |
1761731322107133952 |
| score |
8.893527 |